446 related articles for article (PubMed ID: 19997689)
1. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors.
Haslund P; Lee RA; Jemec GB
Acta Derm Venereol; 2009 Nov; 89(6):595-600. PubMed ID: 19997689
[TBL] [Abstract][Full Text] [Related]
2. The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review.
van Rappard DC; Limpens J; Mekkes JR
J Dermatolog Treat; 2013 Oct; 24(5):392-404. PubMed ID: 22397574
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept.
Poulin Y
J Cutan Med Surg; 2009; 13(4):221-5. PubMed ID: 19706231
[TBL] [Abstract][Full Text] [Related]
4. Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review.
Shuja F; Chan CS; Rosen T
Dermatol Clin; 2010 Jul; 28(3):511-21, 523-4; quiz 522-3. PubMed ID: 20510761
[TBL] [Abstract][Full Text] [Related]
5. Etanercept: effective in the management of hidradenitis suppurativa.
Cusack C; Buckley C
Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
Trent JT; Kerdel FA
Dermatol Nurs; 2005 Apr; 17(2):97-107. PubMed ID: 15916184
[TBL] [Abstract][Full Text] [Related]
7. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
[TBL] [Abstract][Full Text] [Related]
8. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
Kerdel FA
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
[TBL] [Abstract][Full Text] [Related]
9. TNF-α antagonists beyond approved indications: stories of success and prospects for the future.
Karampetsou MP; Liossis SN; Sfikakis PP
QJM; 2010 Dec; 103(12):917-28. PubMed ID: 20802008
[TBL] [Abstract][Full Text] [Related]
10. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials.
Maarouf M; Clark AK; Lee DE; Shi VY
J Dermatolog Treat; 2018 Aug; 29(5):441-449. PubMed ID: 29098911
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
Brunasso AM; Massone C
Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
[No Abstract] [Full Text] [Related]
12. Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature.
Bahillo Monné C; Honorato Guerra S; Schoendorff Ortega C; Gargallo Quintero AB
Dermatology; 2014; 229(4):279-87. PubMed ID: 25472035
[TBL] [Abstract][Full Text] [Related]
13. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
Arenbergerova M; Gkalpakiotis S; Arenberger P
Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
[TBL] [Abstract][Full Text] [Related]
14. Use of biological treatments in patients with hidradenitis suppurativa.
Martin-Ezquerra G; Masferrer E; Masferrer-Niubò M; Ferran M; Sánchez-Regaña M; Collgros H; Bordas X; Notario J; Alsina M; Gil I; Izquierdo N; Aparicio G; Mollet J; Garcia-Patos V; Pujol RM
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):56-60. PubMed ID: 24629001
[TBL] [Abstract][Full Text] [Related]
15. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
Brunasso AM; Massone C
Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
[No Abstract] [Full Text] [Related]
16. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?
Alhusayen R; Shear NH
Am J Clin Dermatol; 2012 Oct; 13(5):283-91. PubMed ID: 22676319
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
Peterson GC; Preston A; Frieder J; Wang X; Paek SY
Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical Hidradenitis Suppurativa in Patients Receiving TNF-α Inhibitors: Case Series, Systematic Review, and Case Meta-Analysis.
Salvador-Rodriguez L; Montero-Vílchez T; Arias-Santiago S; Molina-Leyva A
Dermatology; 2020; 236(4):307-313. PubMed ID: 32135533
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
Mekkes JR; Bos JD
Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
[TBL] [Abstract][Full Text] [Related]
20. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa.
Lee RA; Dommasch E; Treat J; Sciacca-Kirby J; Chachkin S; Williams J; Shin DB; Leyden JJ; Vittorio C; Gelfand JM
J Am Acad Dermatol; 2009 Apr; 60(4):565-73. PubMed ID: 19185954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
